{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:48:44Z","timestamp":1790617724098,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jpet.2026.104986","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:15:11Z","timestamp":1784042111000},"page":"104986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computational pharmacology and in silico clinical trials for the development of drugs from natural products: A review of advances, opportunities, and challenges"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3744-3038","authenticated-orcid":false,"given":"Chinonyelum Emmanuel","family":"Agbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinemelum Kingsley","family":"Nwankwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Chinaecherem","family":"Onyehalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy Chisom","family":"Agu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinonso","family":"Opah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwuemeka Sylvester","family":"Nworu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2026.104986_bib1","first-page":"420","article-title":"Natural products as reservoirs of novel therapeutic agents","volume":"17","author":"Mushtaq","year":"2018","journal-title":"EXCLI J"},{"issue":"5","key":"10.1016\/j.jpet.2026.104986_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/17460441.2019.1582639","article-title":"Are we seeing a resurgence in the use of natural products for new drug discovery?","volume":"14","author":"Li","year":"2019","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"10.1016\/j.jpet.2026.104986_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/metabo2020303","article-title":"A historical overview of natural products in drug discovery","volume":"2","author":"Dias","year":"2012","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.13005\/bpj\/272","article-title":"Natural product in drug discovery: back to future","volume":"4","author":"Shelar","year":"2011","journal-title":"Biomed Pharmacol J"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1039\/C3NP70063A","article-title":"Natural products as starting points for the synthesis of complex and diverse compounds","volume":"31","author":"Morrison","year":"2014","journal-title":"Nat Prod Rep"},{"issue":"2\u20133","key":"10.1016\/j.jpet.2026.104986_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10295-015-1691-9","article-title":"Natural products as probes in pharmaceutical research","volume":"43","author":"Schmitt","year":"2016","journal-title":"J Ind Microbiol Biotechnol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104986_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4172\/jaa.1000025","article-title":"Drug discovery","volume":"2","author":"Prakash","year":"2010","journal-title":"J Antivir Antiretrovir"},{"issue":"2","key":"10.1016\/j.jpet.2026.104986_bib8","first-page":"6","article-title":"Regulatory readiness level: a tool to enhance early regulatory adoption in academic discovery","volume":"15","author":"McGowran","year":"2020","journal-title":"Level 3"},{"issue":"2","key":"10.1016\/j.jpet.2026.104986_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/molecules27020349","article-title":"Modern approaches in the discovery and development of plant-based natural products and their analogues as potential therapeutic agents","volume":"27","author":"Najmi","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.jpet.2026.104986_bib10","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: a review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol Adv"},{"issue":"3","key":"10.1016\/j.jpet.2026.104986_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/wsbm.1337","article-title":"In silico methods for drug repurposing and pharmacology","volume":"8","author":"Hodos","year":"2016","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bjp.0707306","article-title":"In silico pharmacology for drug discovery: applications to targets and beyond","volume":"152","author":"Ekins","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104986_bib13","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/bib\/bby043","article-title":"In silico clinical trials: concepts and early adoptions","volume":"20","author":"Pappalardo","year":"2019","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.jpet.2026.104986_bib14","first-page":"262","article-title":"In silico clinical trials \u2013 review","volume":"12","author":"Santhosh","year":"2023","journal-title":"Int J Sci Res"},{"issue":"12","key":"10.1016\/j.jpet.2026.104986_bib15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S1359-6446(03)02713-2","article-title":"Drugs from the deep: marine natural products as drug candidates","volume":"8","author":"Haefner","year":"2003","journal-title":"Drug Discov Today"},{"issue":"10","key":"10.1016\/j.jpet.2026.104986_bib16","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/j.ejmech.2011.07.057","article-title":"Natural products: an evolving role in future drug discovery","volume":"46","author":"Mishra","year":"2011","journal-title":"Eur J Med Chem"},{"issue":"12","key":"10.1016\/j.jpet.2026.104986_bib17","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1021\/np040106y","article-title":"The role of natural product chemistry in drug discovery","volume":"67","author":"Butler","year":"2004","journal-title":"J Nat Prod"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1351\/pac200577010007","article-title":"Biodiversity: a continuing source of novel drug leads","volume":"77","author":"Cragg","year":"2005","journal-title":"Pure Appl Chem"},{"issue":"6","key":"10.1016\/j.jpet.2026.104986_bib19","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","author":"Cragg","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.jpet.2026.104986_bib20","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/ja00738a045","article-title":"Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia","volume":"93","author":"Wani","year":"1971","journal-title":"J Am Chem Soc"},{"issue":"35","key":"10.1016\/j.jpet.2026.104986_bib21","doi-asserted-by":"crossref","first-page":"10210","DOI":"10.1002\/anie.201601967","article-title":"Artemisinin-A gift from traditional Chinese medicine to the world (Nobel Lecture)","volume":"55","author":"Tu","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"issue":"3","key":"10.1016\/j.jpet.2026.104986_bib22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/np100550t","article-title":"Modern natural products drug discovery and its relevance to biodiversity conservation","volume":"74","author":"Kingston","year":"2011","journal-title":"J Nat Prod"},{"key":"10.1016\/j.jpet.2026.104986_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1168243","article-title":"Drug discovery and natural products: end of an era or an endless frontier?","volume":"325","author":"Li","year":"2009","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jpet.2026.104986_bib24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol Pharm"},{"issue":"13","key":"10.1016\/j.jpet.2026.104986_bib25","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2165\/11317010-000000000-00000","article-title":"Interactions between herbal medicines and prescribed drugs: an updated systematic review","volume":"69","author":"Izzo","year":"2009","journal-title":"Drugs"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2026.104986_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0021-9673(03)00303-0","article-title":"Liquid chromatography with ultraviolet absorbance-mass spectrometric detection and with nuclear magnetic resonance spectroscopy: a powerful combination for the on-line structural investigation of plant metabolites","volume":"1000","author":"Wolfender","year":"2003","journal-title":"J Chromatogr A"},{"issue":"7446","key":"10.1016\/j.jpet.2026.104986_bib27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature12051","article-title":"High-level semi-synthetic production of the potent antimalarial artemisinin","volume":"496","author":"Paddon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jpet.2026.104986_bib28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fchem.2020.00726","article-title":"Computational approaches in preclinical studies on drug discovery and development","volume":"8","author":"Wu","year":"2020","journal-title":"Front Chem"},{"issue":"18","key":"10.1016\/j.jpet.2026.104986_bib29","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1359-6446(03)02828-9","article-title":"ADME-Tox in drug discovery: integration of experimental and computational technologies","volume":"8","author":"Yu","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jpet.2026.104986_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jpet.2026.104986_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"6","key":"10.1016\/j.jpet.2026.104986_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1517\/17460441.2010.484460","article-title":"Virtual screening with AutoDock: theory and practice","volume":"5","author":"Cosconati","year":"2010","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.jpet.2026.104986_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jiec.2019.12.009","article-title":"Effect of ligand torsion number on the AutoDock mediated prediction of protein-ligand binding affinity","volume":"83","author":"Sriramulu","year":"2020","journal-title":"J Ind Eng Chem"},{"issue":"12","key":"10.1016\/j.jpet.2026.104986_bib34","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/psp4.12473","article-title":"Open systems pharmacology community-an open access, open source, open science approach to modeling and simulation in pharmaceutical sciences","volume":"8","author":"Lippert","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.jpet.2026.104986_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-4939-7201-2_18","article-title":"Docking and virtual screening in drug discovery","volume":"1647","author":"Kontoyianni","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40160-2","article-title":"Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management","volume":"13","author":"Agu","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2026.104986_bib37","article-title":"Applications of molecular docking in natural products-based drug discovery","volume":"20","author":"Asiamah","year":"2023","journal-title":"Sci Afr"},{"issue":"6","key":"10.1016\/j.jpet.2026.104986_bib38","first-page":"1417","article-title":"Molecular docking-based virtual screening, drug-likeness, and pharmacokinetic profiling of some anti-Salmonella typhimurium cephalosporin derivatives","volume":"18","author":"Ameji","year":"2023","journal-title":"J Taibah Univ Med Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib39","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1038\/s41598-021-83626-x","article-title":"Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein","volume":"11","author":"Opo","year":"2021","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.jpet.2026.104986_bib40","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3390\/biom10111493","article-title":"XIAP\u2019s profile in human cancer","volume":"10","author":"Tu","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpet.2026.104986_bib42","series-title":"Computational Phytochemistry","first-page":"187","article-title":"Application of computation in creating dereplicated phytochemical libraries","author":"Nahar","year":"2024"},{"key":"10.1016\/j.jpet.2026.104986_bib43","first-page":"15","article-title":"The significance of phytochemicals in drug development and disease prevention","volume":"16","author":"Trant","year":"2024","journal-title":"Der Pharma Lett"},{"key":"10.1016\/j.jpet.2026.104986_bib44","series-title":"Phytochemistry: An In-silico and In-vitro Update","first-page":"351","article-title":"In-silico tools in phytochemical research","author":"Singh","year":"2019"},{"issue":"18","key":"10.1016\/j.jpet.2026.104986_bib45","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13321-020-00424-9","article-title":"Review on natural products databases: where to find data in 2020","volume":"12","author":"Sorokina","year":"2020","journal-title":"J Cheminform"},{"issue":"5","key":"10.1016\/j.jpet.2026.104986_bib47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/ph15050646","article-title":"Drug design by pharmacophore and virtual screening approach","volume":"15","author":"Giordano","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jpet.2026.104986_bib48","article-title":"Structure-based pharmacophore modeling, virtual screening, and molecular dynamics simulation studies for identification of Plasmodium falciparum 5-aminolevulinate synthase inhibitors","volume":"9","author":"Oduselu","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jpet.2026.104986_bib49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.sajb.2018.06.019","article-title":"Modulation of aromatase by natural compounds\u2014a pharmacophore guided molecular modelling simulations","volume":"120","author":"Rampogu","year":"2019","journal-title":"South Afr J Bot"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib50","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41597-024-03793-0","article-title":"PharmaBench: enhancing ADMET benchmarks with large language models","volume":"11","author":"Niu","year":"2024","journal-title":"Sci Data"},{"issue":"2","key":"10.1016\/j.jpet.2026.104986_bib51","first-page":"503","article-title":"In silico molecular docking analysis of potential antidiabetic phytochemicals from Ocimum sanctum L. against therapeutic targets of type 2 diabetes","volume":"12","author":"Garg","year":"2023","journal-title":"Ann Phytomedicine Int J"},{"issue":"4","key":"10.1016\/j.jpet.2026.104986_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5455\/jabet.2020.d157","article-title":"Identification of potential SARS-CoV-2 main protease inhibitors from Ficus Carica Latex: an in-silico approach","volume":"3","author":"Ali","year":"2020","journal-title":"J Adv Biotechnol Exp Ther"},{"issue":"11","key":"10.1016\/j.jpet.2026.104986_bib53","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1124\/dmd.115.065920","article-title":"Physiologically based pharmacokinetic (PBPK) modeling and simulation approaches: a systematic review of published models, applications, and model verification","volume":"43","author":"Sager","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"14","key":"10.1016\/j.jpet.2026.104986_bib54","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1021\/acs.jcim.2c00699","article-title":"Prediction accuracy of production ADMET models as a function of version: activity cliffs rule","volume":"62","author":"Sheridan","year":"2022","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.jpet.2026.104986_bib55","series-title":"Drug design: the machine learning roles","first-page":"1","author":"El-Telbany","year":"2014"},{"key":"10.1016\/j.jpet.2026.104986_bib56","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.csbj.2024.07.003","article-title":"Artificial intelligence in antidiabetic drug discovery: the advances in QSAR and the prediction of \u03b1-glucosidase inhibitors","volume":"23","author":"Odugbemi","year":"2024","journal-title":"Comput Struct Biotechnol J"},{"issue":"24","key":"10.1016\/j.jpet.2026.104986_bib57","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.3390\/molecules25246057","article-title":"QSAR model for predicting the cannabinoid receptor 1 binding affinity and dependence potential of synthetic cannabinoids","volume":"25","author":"Lee","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.jpet.2026.104986_bib58","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s11030-024-11070-w","article-title":"Integrating traditional QSAR and read-across-based regression models for predicting potential anti-leishmanial azole compounds","volume":"29","author":"Nandi","year":"2025","journal-title":"Mol Divers"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13321-018-0325-4","article-title":"Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery","volume":"11","author":"Bosc","year":"2019","journal-title":"J Cheminform"},{"issue":"8","key":"10.1016\/j.jpet.2026.104986_bib60","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/tx200148a","article-title":"Predicting drug-induced hepatotoxicity using QSAR and toxicogenomics approaches","volume":"24","author":"Low","year":"2011","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jpet.2026.104986_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fphar.2019.00031","article-title":"Construction of a quantitative structure activity relationship (QSAR) model to predict the absorption of cephalosporins in zebrafish for toxicity study","volume":"10","author":"Liu","year":"2019","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.jpet.2026.104986_bib62","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/acscombsci.7b00056","article-title":"Machine learning using combined structural and chemical descriptors for prediction of methane adsorption performance of metal organic frameworks (MOFs)","volume":"19","author":"Pardakhti","year":"2017","journal-title":"ACS Comb Sci"},{"key":"10.1016\/j.jpet.2026.104986_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.nexres.2024.100012","article-title":"Integrating computational 3D-QSAR and pharmacophore modelling in diverse natural phytochemicals library for targeted therapy against breast cancer estrogen receptors","volume":"1","author":"Islam","year":"2024","journal-title":"Next Res"},{"key":"10.1016\/j.jpet.2026.104986_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jtbi.2018.09.030","article-title":"MIA-QSAR based model for bioactivity prediction of flavonoid derivatives as acetylcholinesterase inhibitors","volume":"459","author":"Muthukumaran","year":"2018","journal-title":"J Theor Biol"},{"key":"10.1016\/j.jpet.2026.104986_bib65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13020-020-00313-1","article-title":"Predictive QSAR model confirms flavonoids in Chinese medicine can activate voltage-gated calcium (CaV) channel in osteogenesis","volume":"15","author":"Chan","year":"2020","journal-title":"Chin Med"},{"issue":"2","key":"10.1016\/j.jpet.2026.104986_bib66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-023-00832-0","article-title":"Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR","volume":"23","author":"Tropsha","year":"2024","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.jpet.2026.104986_bib67","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/jm4004285","article-title":"QSAR modeling: Where have you been? Where are you going to?","volume":"57","author":"Cherkasov","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpet.2026.104986_bib68","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1741-7007-9-71","article-title":"Molecular dynamics simulations and drug discovery","volume":"9","author":"Durrant","year":"2011","journal-title":"BMC Biol"},{"key":"10.1016\/j.jpet.2026.104986_bib69","series-title":"Advances in Protein Molecular and Structural Biology Methods","first-page":"455","article-title":"Applications of molecular dynamics simulations in drug discovery","author":"Lin","year":"2022"},{"issue":"9","key":"10.1016\/j.jpet.2026.104986_bib70","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpet.2026.104986_bib124","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1038\/s41598-021-82857-2","article-title":"In silico identification of natural products from traditional Chinese medicine for cancer immunotherapy","volume":"11","author":"Cai","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2026.104986_bib125","article-title":"In silico investigation of phytoconstituents from Indian medicinal herb \u201cTinospora cordifolia (Giloy)\u201d against SARS-CoV-2 (COVID-19) by molecular dynamics approach","author":"Chowdhury","year":"2020","journal-title":"arXiv"},{"key":"10.1016\/j.jpet.2026.104986_bib126","doi-asserted-by":"crossref","first-page":"929430","DOI":"10.3389\/fcimb.2022.929430","article-title":"In silico investigation and potential therapeutic approaches of natural products for COVID-19: computer-aided drug design perspective","volume":"12","author":"Rahman","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jpet.2026.104986_bib127","doi-asserted-by":"crossref","first-page":"1273149","DOI":"10.3389\/fchem.2023.1273149","article-title":"In silico and in vitro study of bioactive compounds of Nigella sativa for targeting neuropilins in breast cancer","volume":"11","author":"Zafar","year":"2023","journal-title":"Front Chem"},{"key":"10.1016\/j.jpet.2026.104986_bib128","doi-asserted-by":"crossref","first-page":"107102","DOI":"10.1016\/j.compbiolchem.2019.107102","article-title":"In silico identification of natural products with anticancer activity using a chemo-structural database of Brazilian biodiversity","volume":"83","author":"Gal\u00facio","year":"2019","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.jpet.2026.104986_bib129","doi-asserted-by":"crossref","first-page":"128798","DOI":"10.1016\/j.bmcl.2022.128798","article-title":"Discovery of (2-phenylthiazol-4-yl)urea derivatives that induce neuronal differentiation from mesenchymal stem cells","volume":"69","author":"Lou","year":"2022","journal-title":"Bioorgan Med Chem Lett"},{"key":"10.1016\/j.jpet.2026.104986_bib130","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3389\/fphar.2018.00800","article-title":"In silico discovery of plant-origin natural product inhibitors of tumor necrosis factor (TNF) and receptor activator of NF-\u03baB ligand (RANKL)","volume":"9","author":"Melagraki","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2026.104986_bib131","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.3390\/molecules27207024","article-title":"Does the metabolome of wild-like dendrobium officinale of different origins have regional differences?","volume":"27","author":"Lan","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2026.104986_bib132","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.3390\/ijms23136912","article-title":"Multi-step in silico discovery of natural drugs against COVID-19 targeting main protease","volume":"23","author":"Elkaeed","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.jpet.2026.104986_bib133","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2018.9027","article-title":"Capturing antibacterial natural products with in silico techniques","author":"Masalha","year":"2018","journal-title":"Mol Med Report"},{"key":"10.1016\/j.jpet.2026.104986_bib134","doi-asserted-by":"crossref","first-page":"751032","DOI":"10.3389\/fphar.2021.751032","article-title":"Phytomedicine in disease management: in-silico analysis of the binding affinity of artesunate and azadirachtin for malaria treatment","volume":"12","author":"Okoh","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2026.104986_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.compbiomed.2014.01.003","article-title":"Revealing pharmacodynamics of medicinal plants using in silico approach: a case study with wet lab validation","volume":"47","author":"Singh","year":"2014","journal-title":"Comput Biol Med"},{"issue":"45","key":"10.1016\/j.jpet.2026.104986_bib71","doi-asserted-by":"crossref","first-page":"31578","DOI":"10.1039\/D3RA06831E","article-title":"Challenges in natural product-based drug discovery assisted with in silico-based methods","volume":"13","author":"Simoben","year":"2023","journal-title":"RSC Adv"},{"issue":"8","key":"10.1016\/j.jpet.2026.104986_bib72","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/pharmaceutics17081002","article-title":"In silico ADME methods used in the evaluation of natural products","volume":"17","author":"Ancuceanu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpet.2026.104986_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114553","article-title":"Drug discovery from natural products \u2013 old problems and novel solutions for the treatment of neurodegenerative diseases","volume":"210","author":"Maitra","year":"2022","journal-title":"J Pharm Biomed Anal"},{"issue":"8","key":"10.1016\/j.jpet.2026.104986_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1012289","article-title":"Credibility assessment of in silico clinical trials for medical devices","volume":"20","author":"Pathmanathan","year":"2024","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jpet.2026.104986_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114784","article-title":"Integrative toxicogenomics: advancing precision medicine and toxicology through artificial intelligence and OMICs technology","volume":"163","author":"Singh","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jpet.2026.104986_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fsysb.2023.1174647","article-title":"A practical guide for the generation of model-based virtual clinical trials","volume":"3","author":"Craig","year":"2023","journal-title":"Front Syst Biol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104986_bib77","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s43441-025-00893-w","article-title":"In silico clinical trials in drug development: a systematic review","volume":"60","author":"Chen","year":"2026","journal-title":"Ther Innov Regul Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib78","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/ddc3010011","article-title":"Plant-derived natural products: a source for drug discovery and development","volume":"3","author":"Chaachouay","year":"2024","journal-title":"Drugs Drug Candidates"},{"issue":"3","key":"10.1016\/j.jpet.2026.104986_bib79","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3390\/ph18030419","article-title":"Potential benefits of in silico methods: a promising alternative in natural compound\u2019s drug discovery and repurposing for HBV therapy","volume":"18","author":"Ugbaja","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jpet.2026.104986_bib80","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ymeth.2020.01.011","article-title":"In silico trials: verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products","volume":"185","author":"Viceconti","year":"2021","journal-title":"Methods"},{"issue":"22\u201323","key":"10.1016\/j.jpet.2026.104986_bib81","first-page":"5465","article-title":"Complete populations of virtual patients for in silico clinical trials","volume":"36","author":"Sinisi","year":"2020","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.jpet.2026.104986_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103605","article-title":"Virtual patients, digital twins and causal disease models: paving the ground for in silico clinical trials","volume":"28","author":"Moingeon","year":"2023","journal-title":"Drug Discov Today"},{"issue":"8","key":"10.1016\/j.jpet.2026.104986_bib83","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s11095-022-03257-3","article-title":"Role of disease progression models in drug development","volume":"39","author":"Barrett","year":"2022","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.jpet.2026.104986_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005874","article-title":"Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment","volume":"13","author":"Gaddy","year":"2017","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib85","doi-asserted-by":"crossref","first-page":"11","DOI":"10.47852\/bonviewMEDIN42023842","article-title":"In silico studies as support for natural products research","volume":"2","author":"Tessema","year":"2024","journal-title":"Medinformatics"},{"issue":"7","key":"10.1016\/j.jpet.2026.104986_bib86","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s40262-019-00736-6","article-title":"Physiologically based pharmacokinetic modelling of hyperforin to predict drug interactions with St John\u2019s Wort","volume":"58","author":"Adiwidjaja","year":"2019","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib87","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2193-9616-1-12","article-title":"In silico drug metabolism and pharmacokinetic profiles of natural products from medicinal plants in the Congo basin","volume":"1","author":"Ntie-Kang","year":"2013","journal-title":"Silico Pharmacol"},{"issue":"26","key":"10.1016\/j.jpet.2026.104986_bib88","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1021\/acsomega.0c01581","article-title":"In silico ADME\/Tox profiling of natural products: a focus on BIOFACQUIM","volume":"5","author":"Dur\u00e1n-Iturbide","year":"2020","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.jpet.2026.104986_bib89","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/pharmaceutics16030332","article-title":"Advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare","volume":"16","author":"Marques","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib90","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41746-024-01188-4","article-title":"From virtual patients to digital twins in immuno-oncology: lessons learned from mechanistic quantitative systems pharmacology modeling","volume":"7","author":"Wang","year":"2024","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.jpet.2026.104986_bib91","article-title":"Predicting pharmacodynamic effects through early drug discovery with artificial intelligence-physiologically based pharmacokinetic (AI-PBPK) modelling","volume":"15","author":"Wu","year":"2024","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104986_bib92","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.drudis.2018.01.039","article-title":"The rise of deep learning in drug discovery","volume":"23","author":"Chen","year":"2018","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib93","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s44250-024-00163-w","article-title":"The role and impact of new technologies on healthcare systems","volume":"3","author":"Sinha","year":"2024","journal-title":"Discov Health Syst"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42004-023-01054-6","article-title":"Variational autoencoder-based chemical latent space for large molecular structures with 3D complexity","volume":"6","author":"Ochiai","year":"2023","journal-title":"Commun Chem"},{"key":"10.1016\/j.jpet.2026.104986_bib95","article-title":"Natural product databases for drug discovery: features and applications","volume":"2","author":"Zeng","year":"2024","journal-title":"Pharm Sci Adv"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44385-024-00003-9","article-title":"Application of artificial intelligence in drug-target interactions prediction: a review","volume":"2","author":"Liao","year":"2025","journal-title":"NPJ Biomed Innov"},{"issue":"6557","key":"10.1016\/j.jpet.2026.104986_bib97","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.abj8754","article-title":"Accurate prediction of protein structures and interactions using a three-track neural network","volume":"373","author":"Baek","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib98","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41392-023-01381-z","article-title":"AlphaFold2 and its applications in the fields of biology and medicine","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1016\/j.jpet.2026.104986_bib99","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/molecules29040832","article-title":"Recent progress of protein tertiary structure prediction","volume":"29","author":"Wuyun","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2026.104986_bib100","article-title":"Bridging the gap between computational biology and experimental validation in drug discovery","author":"Elhadi","year":"2024","journal-title":"LinkedIn"},{"issue":"4","key":"10.1016\/j.jpet.2026.104986_bib101","first-page":"578","article-title":"The importance of in-silico studies in drug discovery","volume":"2","author":"Roney","year":"2024","journal-title":"Intell Pharm"},{"key":"10.1016\/j.jpet.2026.104986_bib102","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1758-2946-6-16","article-title":"Experimental validation of FINDSITE(comb) virtual ligand screening results for eight proteins yields novel nanomolar and micromolar binders","volume":"6","author":"Srinivasan","year":"2014","journal-title":"J Cheminform"},{"key":"10.1016\/j.jpet.2026.104986_bib103","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.biophys.27.1.249","article-title":"Inhibitors of HIV-1 protease: a major success of structure-assisted drug design","volume":"27","author":"Wlodawer","year":"1998","journal-title":"Annu Rev Biophys Biomol Struct"},{"issue":"10","key":"10.1016\/j.jpet.2026.104986_bib104","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2174\/156802607780906744","article-title":"Structure based drug design for HIV protease: from molecular modeling to cheminformatics","volume":"7","author":"Volarath","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jpet.2026.104986_bib105","first-page":"51","article-title":"In silico clinical trials: is it possible?","volume":"2716","author":"Ars\u00e8ne","year":"2024"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib106","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s44387-026-00094-2","article-title":"Data-hugging shields proprietary AI models from research that could disprove them","volume":"2","author":"Karpurapu","year":"2026","journal-title":"NPJ Artif Intell"},{"issue":"3","key":"10.1016\/j.jpet.2026.104986_bib107","first-page":"201","article-title":"Issues in patenting \u2018artificial intelligence\u2019 from an EPO perspective","volume":"19","author":"M\u00fcller","year":"2024","journal-title":"J Intellect Prop Law Pract"},{"issue":"3","key":"10.1016\/j.jpet.2026.104986_bib108","article-title":"A systematic review of cardiac in-silico clinical trials","volume":"5","author":"Rodero","year":"2023","journal-title":"Prog Biomed Eng (Bristol)"},{"key":"10.1016\/j.jpet.2026.104986_bib109","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2288-14-40","article-title":"External validation of multivariable prediction models: a systematic review of methodological conduct and reporting","volume":"14","author":"Collins","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","article-title":"External validation of prognostic models: what, why, how, when and where?","volume":"14","author":"Ramspek","year":"2021","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.jpet.2026.104986_bib111","doi-asserted-by":"crossref","first-page":"37","DOI":"10.18203\/2349-3259.ijct20161408","article-title":"In silico clinical trials: how computer simulation will transform the biomedical industry","volume":"3","author":"Viceconti","year":"2016","journal-title":"Int J Clin Trials"},{"key":"10.1016\/j.jpet.2026.104986_bib112","series-title":"Focus area: model-informed product development","year":"2022"},{"issue":"2","key":"10.1016\/j.jpet.2026.104986_bib113","article-title":"Reproducibility in machine learning-based research: overview, barriers and drivers","volume":"46","author":"Semmelrock","year":"2025","journal-title":"AI Mag"},{"key":"10.1016\/j.jpet.2026.104986_bib114","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.future.2021.06.014","article-title":"Do machine learning platforms provide out-of-the-box reproducibility?","volume":"126","author":"Gundersen","year":"2022","journal-title":"Future Gener Comput Syst"},{"issue":"4","key":"10.1016\/j.jpet.2026.104986_bib115","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3390\/make4040045","article-title":"How do deep-learning framework versions affect the reproducibility of neural network models?","volume":"4","author":"Shahriari","year":"2022","journal-title":"Mach Learn Knowl Extr"},{"key":"10.1016\/j.jpet.2026.104986_bib116","first-page":"227","article-title":"Quantum-mechanical\/molecular-mechanical (QM\/MM) simulations for understanding enzyme dynamics","volume":"2397","author":"Mehmood","year":"2022"},{"issue":"7873","key":"10.1016\/j.jpet.2026.104986_bib117","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2025","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jpet.2026.104986_bib118","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.18311\/jnr\/2025\/48515","article-title":"Revolutionizing natural product science with AI: integrating diverse data and knowledge graphs","volume":"25","author":"Dave","year":"2025","journal-title":"J Nat Remedies"},{"issue":"2","key":"10.1016\/j.jpet.2026.104986_bib119","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/mi16020201","article-title":"Organ-on-a-chip applications in microfluidic platforms","volume":"16","author":"An","year":"2025","journal-title":"Micromachines (Basel)"},{"key":"10.1016\/j.jpet.2026.104986_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101750","article-title":"Recent advances in 3D bioprinted tumor models for personalized medicine","volume":"37","author":"Gnatowski","year":"2023","journal-title":"Transl Oncol"},{"key":"10.1016\/j.jpet.2026.104986_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.plaphy.2024.108511","article-title":"Metabolic engineering for enhanced terpenoid production: leveraging new horizons with an old technique","volume":"210","author":"Kumari","year":"2024","journal-title":"Plant Physiol Biochem"},{"key":"10.1016\/j.jpet.2026.104986_bib122","series-title":"FDA proposes framework to advance credibility of AI models used for drug and biological product submissions","year":"2025"},{"issue":"1","key":"10.1016\/j.jpet.2026.104986_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2016.18","article-title":"The FAIR guiding principles for scientific data management and stewardship","volume":"3","author":"Wilkinson","year":"2016","journal-title":"Sci Data"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:15:14Z","timestamp":1787922914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526011869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":134,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022356526011869"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104986","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational pharmacology and in silico clinical trials for the development of drugs from natural products: A review of advances, opportunities, and challenges","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104986"}}